These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 4862827)
1. The possible significance of cerebral dopamine for neurology and psychiatry. van Praag HM Psychiatr Neurol Neurochir; 1967; 70(5):361-79. PubMed ID: 4862827 [No Abstract] [Full Text] [Related]
2. Schizophrenia and pink spot. Stam FC; Heslinga FJ; van Tilburg W Psychiatr Neurol Neurochir; 1969; 72(6):513-24. PubMed ID: 5369242 [No Abstract] [Full Text] [Related]
4. [Cerebral biochemical disorders and mental diseases. A propos of the "pink spot"]. Delay J; Boissier JR; Deniker P; Simon P; Ginestet D; Wirz-Justice A Encephale; 1969; 58(4):360-76. PubMed ID: 5378191 [No Abstract] [Full Text] [Related]
5. Biochemical aspects of schizophrenia. Lewis ME Essays Neurochem Neuropharmacol; 1980; 4():1-67. PubMed ID: 6104597 [No Abstract] [Full Text] [Related]
6. A new tremorgen: 3,4-dimethylphenethylamine. Schweitzer JW; Friedhoff AJ; Roll FJ Arch Int Pharmacodyn Ther; 1969 Aug; 180(2):385-90. PubMed ID: 5348408 [No Abstract] [Full Text] [Related]
7. [On the problem of the metabolism of dopamine in the brain of patients with parkinsonism]. Travenets IA Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(10):1505-7. PubMed ID: 6000312 [No Abstract] [Full Text] [Related]
8. The metabolism of brain dopamine in human parkinsonism. Hornykiewicz O Riv Patol Nerv Ment; 1970 Oct; 91(5):281-6. PubMed ID: 5525774 [No Abstract] [Full Text] [Related]
10. [Biochemical studies of schizophrenia]. Kakimoto Y Nihon Rinsho; 1976 Sep; 34(9):2706-11. PubMed ID: 1033308 [No Abstract] [Full Text] [Related]
11. [Dopamine and parkinsonism]. Siegfried J Schweiz Med Wochenschr; 1968 Mar; 98(11):429-31. PubMed ID: 5700507 [No Abstract] [Full Text] [Related]
12. Extrapyramidal dopamine regulation by cholecystokinin and its role in Parkinson's disease. Diamond BI; Pasinetti G; Hitri A; Borison RL Adv Neurol; 1984; 40():483-8. PubMed ID: 6695625 [No Abstract] [Full Text] [Related]
13. The identity of the so-called pink spot in schizophrenia and Parkinson's disease. Heslinga FJ; van Tilburg W; Stam FC Psychiatr Neurol Neurochir; 1970; 73(3):157-64. PubMed ID: 5310324 [No Abstract] [Full Text] [Related]
14. [Biochemical aspects of schizophrenia]. van Zwieten PA Arzneimittelforschung; 1967 May; 17(5):553-6. PubMed ID: 4873894 [No Abstract] [Full Text] [Related]
16. Endogenous regeneration in Parkinson's disease: do we need orthotopic dopaminergic neurogenesis? Hermann A; Storch A Stem Cells; 2008 Nov; 26(11):2749-52. PubMed ID: 18719222 [No Abstract] [Full Text] [Related]
17. The "pink spot", 3,4-dimethoxyphenylethylamine and dopamine. Relationship to Parkinson's disease and to schizophrenia. Barbeau A Rev Can Biol; 1967 Mar; 26(1):55-79. PubMed ID: 4865100 [No Abstract] [Full Text] [Related]
18. [Microdialysis cerebral. Main application of this technique]. Blanco-Lezcano L; Pavón-Fuentes N; Blanco-Lezcano V Rev Neurol; 2001 Sep 1-15; 33(5):464-70. PubMed ID: 11727216 [TBL] [Abstract][Full Text] [Related]
19. Is brain damage the cause of "pink spot"? Nunn RF; Wheeler RH Nature; 1966 Nov; 212(5065):939. PubMed ID: 6004582 [No Abstract] [Full Text] [Related]
20. The neurobiology of dopamine signaling. Girault JA; Greengard P Arch Neurol; 2004 May; 61(5):641-4. PubMed ID: 15148138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]